 - Phase 2 only: Prior chemotherapy or prior treatment with epidermal growth factor receptor EGFR inhibitor, including both tyrosine kinase inhibitors and monoclonal antibodies. There is no limit to the number of therapies for subject being considered for Phase 1b. 